Bangladesh greenlights third phase trial of Sinovac vaccine
Click here to read full article from source
Https, Aug. 28 -- Bangladesh has approved the late-stage trial of a vaccine candidate for the novel coronavirus, developed by China's Sinovac Biotech Ltd.
Health Minister Zahid Maleque announced the development at a media briefing in Dhaka on Thursday.
Addressing the government's discussions with China over the vaccine, Maleque said, "It has been decided that the Chinese company Sinovac will supply its vaccine to Bangladesh. They also want to run trials in Bangladesh. We've held discussions on different levels regarding that."
Prime Minister Sheikh Hasina has been informed about the various vaccine candidates being developed in India, China, Russia and the UK, according to the minister.
To read the full article or to get the complete feed from this publication, please Contact Us